A Multicenter, Prospective, Open-label, Single-arm Clinical Study of the Safety and Feasibility of Using Navigational Bronchoscopy to Perform Interstitial Photodynamic Therapy Using Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors Concordia International Corp.
- 07 Apr 2017 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
- 07 Apr 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Jan 2018.
- 27 Jan 2017 Status changed from not yet recruiting to recruiting.